文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

脓毒症患者PCSK9与血脂的预后价值

[Prognostic value of PCSK9 and blood lipid in patients with sepsis].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论脓毒症患者早期血清PCSK9升高与28天死亡风险独立相关,PCSK9≥208.97 μg/L时28天生存率显著下降,其预后预测价值高于HDL-C、LDL-C和TC。

该研究纳入滨州医学院附属医院重症医学科2021年1月至10月收治的50例脓毒症或脓毒性休克患者(脓毒症19例、脓毒性休克31例)及27例健康对照,检测诊断后24小时内及第1、3、5天血清PCSK9和血脂指标。脓毒症组PCSK9显著高于健康对照组,HDL-C、LDL-C、TC和脂蛋白A显著低于健康对照组(均P<0.01)。28天死亡组PCSK9高于存活组,HDL-C、LDL-C、TC低于存活组(均P<0.01)。ROC曲线显示PCSK9预测28天死亡的AUC为0.748(95%CI 0.611-0.885),高于HDL-C、LDL-C、TC。多因素Logistic回归显示PCSK9是影响脓毒症28天预后的独立危险因素(β=1.014,P=0.020),PCSK9≥208.97 μg/L时28天生存率随PCSK9升高显著下降。

要点

  • 脓毒症患者血清PCSK9显著高于健康对照[μg/L:223.09(198.47, 250.82)vs. 188.00(165.27, 214.90),P<0.01],HDL-C、LDL-C、TC和脂蛋白A显著低于健康对照(均P<0.01)。
  • 28天死亡组PCSK9高于存活组[μg/L:249.58(214.90, 315.77)vs. 207.01(181.50, 244.95),P<0.01],HDL-C、LDL-C、TC低于存活组(均P<0.01)。
  • ROC曲线显示PCSK9预测28天死亡的AUC为0.748(95%CI 0.611-0.885),高于HDL-C 0.710(0.552-0.868)、LDL-C 0.721(0.575-0.867)、TC 0.702(0.550-0.854)。
  • 多因素Logistic回归显示PCSK9是影响脓毒症28天预后的独立危险因素(β=1.014,P=0.020)。
  • Kaplan-Meier生存曲线显示PCSK9≥208.97 μg/L时,随PCSK9升高脓毒症患者28天生存率显著下降。

适用人群与场景

  • ≥18岁、符合Sepsis-3.0诊断标准、2021年1月至10月收治于滨州医学院附属医院重症医学科的脓毒症或脓毒性休克患者(脓毒症19例、脓毒性休克31例)。
  • 同期健康成人27例作为健康对照组。

诊断标准与关键阈值

  • 脓毒症诊断采用Sepsis-3.0诊断标准。
  • PCSK9≥208.97 μg/L时,脓毒症患者28天生存率随PCSK9升高显著下降。

研究设计与关键结果

  • 研究类型为病例对照研究,纳入脓毒症组50例(脓毒症19例、脓毒性休克31例)和健康对照组27例;28天内脓毒症组死亡19例、存活31例。
  • 脓毒症组血清PCSK9高于健康对照组[μg/L:223.09(198.47, 250.82)vs. 188.00(165.27, 214.90),P<0.01];HDL-C[mmol/L:0.82±0.35 vs. 1.45±0.24]、LDL-C[mmol/L:1.53(1.14, 2.47)vs. 2.89(2.55, 3.19)]、TC[mmol/L:2.03(1.39, 2.84)vs. 4.24(3.90, 4.71)]、脂蛋白A[g/L:8.80(5.66, 17.56)vs. 27.03(14.79, 27.03)]均低于健康对照组(均P<0.01)。
  • 脓毒症死亡组PCSK9高于存活组[μg/L:249.58(214.90, 315.77)vs. 207.01(181.50, 244.95),P<0.01];HDL-C[mmol/L:0.64±0.35 vs. 0.93±0.30]、LDL-C[mmol/L:1.32±0.64 vs. 2.08±0.94]、TC[mmol/L:1.39(1.01, 2.23)vs. 2.69(1.72, 3.81)]低于存活组(均P<0.01)。
  • 随疾病进展,脓毒症死亡组和存活组PCSK9均显著低于诊断后1天内(均P<0.05)。
  • ROC曲线显示PCSK9预测28天死亡的AUC为0.748(95%CI 0.611-0.885),HDL-C为0.710(0.552-0.868),LDL-C为0.721(0.575-0.867),TC为0.702(0.550-0.854)。
  • 多因素Logistic回归显示PCSK9是影响脓毒症28天预后的独立危险因素(β=1.014,P=0.020)。
  • Kaplan-Meier生存曲线显示PCSK9≥208.97 μg/L时,随PCSK9升高脓毒症患者28天生存率显著下降。

证据类型、等级与局限

  • 证据类型:病例对照研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为PCSK9、HDL-C、LDL-C和TC均可预测脓毒症患者28天预后,其中PCSK9预后价值最高,PCSK9是影响脓毒症预后的独立危险因素。
  • 作者认为在疾病早期,PCSK9可能对脓毒症预后有较好的预测价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To investigate the prognostic value of proprotein convertase subtilisin/kexin type 9 (PCSK9) and blood lipid indexes in patients with sepsis.

METHODS: Patients with sepsis or septic shock who were ≥ 18 years old and met the Sepsis-3.0 diagnostic criteria admitted to the department of critical care medicine of Binzhou Medical University Hospital from January to October 2021 were enrolled. Healthy adults at the same period were selected as healthy control group. Baseline characteristics, acute physiology and chronic health evaluation II (APACHE II) and sequential organ failure assessment (SOFA) score were recorded. Venous blood samples were collected within 24 hours after diagnosis, and serum PCSK9 was determined by enzyme-linked immunosorbent assay (ELISA) at 1, 3 days and 5 days. Meanwhile, high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC), triglyceride (TG) and lipoprotein A were detected. The differences of each index between sepsis group (28-day death group and survival group) and healthy control group were compared. Meanwhile, the indexes of patients with different severity and 28-day prognosis in sepsis group were compared. Receiver operator characteristic curve (ROC curve) was drawn to evaluate the predictive value of PCSK9 and blood lipid for the prognosis of sepsis. Multivariate Logistic regression was used to analyze the influencing factors for the prognosis of sepsis, and the Kaplan-Meier survival curve at 28th day was drawn.

RESULTS: There were 50 patients in sepsis group (including 19 patients with sepsis, 31 patients with septic shock) and 27 patients in healthy control group. In the sepsis group, 19 patients died and 31 patients survived within 28 days. The serum PCSK9 in the sepsis group was significantly higher than that in the healthy control group [μg/L: 223.09 (198.47, 250.82) vs. 188.00 (165.27, 214.90), P < 0.01], and HDL-C, LDL-C, TC and lipoprotein A were significantly lower than those in the healthy control group [HDL-C (mmol/L): 0.82±0.35 vs. 1.45±0.24, LDL-C (mmol/L): 1.53 (1.14, 2.47) vs. 2.89 (2.55, 3.19), TC (mmol/L): 2.03 (1.39, 2.84) vs. 4.24 (3.90, 4.71), lipoprotein A (g/L): 8.80 (5.66, 17.56) vs. 27.03 (14.79, 27.03), all P < 0.01]. PCSK9 in the sepsis death group was higher than that in the survival group [μg/L: 249.58 (214.90, 315.77) vs. 207.01 (181.50, 244.95), P < 0.01], and the HDL-C, LDL-C and TC were lower than those in the survival group [HDL-C (mmol/L): 0.64±0.35 vs. 0.93±0.30, LDL-C (mmol/L): 1.32±0.64 vs. 2.08±0.94, TC (mmol/L): 1.39 (1.01, 2.23) vs. 2.69 (1.72, 3.81), all P < 0.01]. With the progression of the disease, the PCSK9 in the sepsis death group and the survival group was significantly lower than that within 1 day of diagnosis (all P < 0.05). ROC curve analysis showed that PCSK9 had higher predictive value of 28-day death than HDL-C, LDL-C, TC [area under ROC curve (AUC) and 95% confidence interval (95%CI): 0.748 (0.611-0.885) vs. 0.710 (0.552-0.868), 0.721 (0.575-0.867), 0.702 (0.550-0.854)]. Multivariate Logistic regression analysis showed that PCSK9 was an independent risk factor affecting the 28-day prognosis of sepsis (β value was 1.014, P = 0.020). Kaplan-Meier survival curve analysis showed that when PCSK9 ≥ 208.97 μg/L, with the increase of PCSK9, the 28-day survival rate of sepsis patients decreased significantly.

CONCLUSIONS: PCSK9, HDL-C, LDL-C and TC can all predict the 28-day prognosis of patients with sepsis. The prognostic value of PCSK9 is the highest. PCSK9 is an independent risk factor affecting the prognosis of sepsis. In the early stage of the disease, PCSK9 may have a good predictive value for the prognosis of sepsis. When PCSK9 ≥ 208.97 μg/L, the 28-day survival rate decreased significantly.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Chen X, Huang X, Tian H, et al. [Prognostic value of PCSK9 and blood lipid in patients with sepsis]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 35924517. doi:10.3760/cma.j.cn121430-20211220-01887

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。